Comparison Of Efficacy And Safety Of Thalidomide Vs Hydroxyurea In Thalassemia Patients: A Single-Centre Pilot Study.

Conditions: Beta-Thalassemia Interventions: Drug: Thalidomide 100mg; Drug: Hydroxyurea Sponsors: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials